Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

73.47
+2.413.39%
Post-market: 73.470.00000.00%19:30 EDT
Volume:624.46K
Turnover:45.54M
Market Cap:6.13B
PE:-120.44
High:73.47
Open:71.69
Low:71.69
Close:71.06
52wk High:90.87
52wk Low:48.28
Shares:83.46M
Float Shares:77.19M
Volume Ratio:0.68
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-37.08
PE(LYR):9.44

Loading ...

May 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 18, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 31, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 29, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 24, 2023

Major Issues Report

8-K - Current report